Connect Biopharma Holdings Limited (CNTB) Social Stream
CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CONNECT BIOPHARMA HOLDINGS LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-18 | 3 | $32 | $27 | $30 | $1.12 | 2578.57% |
| 2022-04-08 | 3 | $25 | $19 | $22 | $1.12 | 1864.29% |
| 2022-05-04 | 3 | $13 | $1.5 | $7.833 | $1.12 | 599.38% |
| 2022-06-06 | 4 | $13 | $1.5 | $7.125 | $1.12 | 536.16% |
| 2022-09-15 | 4 | $9 | $1.75 | $5.687 | $1.12 | 407.77% |
| 2023-02-08 | 2 | $7 | $1.75 | $5.187 | $1.12 | 363.12% |
| 2023-04-12 | 3 | $7 | $1.75 | $5.187 | $1.12 | 363.12% |
| 2023-07-11 | 2 | $7 | $5 | $6.333 | $1.12 | 465.45% |
| 2023-09-12 | 1 | $7 | $7 | $7 | $1.12 | 525% |
| 2023-09-13 | 2 | $7 | $5 | $6 | $1.12 | 435.71% |
The Trend in the Analyst Price Target
Over the past 22 months, CNTB's average price target has gone down $24.
CNTB reports an average of 480.32% for its upside potential over the past 31 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 2 | 7 | 1.75 | 5.187 | 1.17 | 343.33% |
| 2023-02-08 | 4 | 7 | 1.75 | 5.187 | 1.17 | 343.33% |
| 2023-04-12 | 2 | 7 | 5.00 | 6.333 | 1.12 | 465.45% |
| 2023-07-11 | 2 | 7 | 5.00 | 6.333 | 1.08 | 486.39% |
| 2023-09-13 | 2 | 7 | 5.00 | 6.000 | 0.78 | 669.23% |
CNTB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 22 months, CNTB's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's upside potential (average analyst target price relative to current price) is greater than 1021.56% of them.
- In the context of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 79.92% of them.
- In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to all US stocks, note that its average analyst price target is higher than 114.34% of that group.
- In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -479.13% of that group.
In the Pharmaceutical Products industry, LVTX, EWTX, and DSGN are the three stocks most similar to CONNECT BIOPHARMA HOLDINGS LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CNTB using the data that counts. Try POWR Ratings for free.